2,4-thiazolidinedione has been researched along with Ovarian Neoplasms in 1 studies
thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bourguignon, LY | 1 |
| Gilad, E | 1 |
| Peyrollier, K | 1 |
1 other study available for 2,4-thiazolidinedione and Ovarian Neoplasms
| Article | Year |
|---|---|
Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration.
Topics: Animals; cdc42 GTP-Binding Protein; Cell Line, Tumor; Cell Movement; Contractile Proteins; Down-Regu | 2007 |